|Articles|March 1, 2001
- Pharmaceutical Executive-03-01-2001
- Volume 0
- Issue 0
Lilly's International Family
Author(s)L.J. Sellers
Sidney Taurel Takes His Global Team Beyond Prozac
Advertisement
Articles in this issue
almost 25 years ago
Research: New Horizonsalmost 25 years ago
Earnings: Tough Times Aheadalmost 25 years ago
Outbreak: Anthrax Alarmalmost 25 years ago
Patents: China on the Genome Mapalmost 25 years ago
Privacy, Pediatrics, and Policyalmost 25 years ago
Update: Punishment and Reprievealmost 25 years ago
Shortage: Vaccine Worriesalmost 25 years ago
Gateway to Japanalmost 25 years ago
SurroundedNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
Novavax Enters $530 Million License Agreement with Pfizer for Vaccine Development
4
Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics
5